Heron Patrick J 4
4 · HilleVax, Inc. · Filed Jun 25, 2025
Insider Transaction Report
Form 4
HilleVax, Inc.HLVX
Heron Patrick J
Director
Transactions
- Award
Common Stock
2025-06-23+17,199→ 17,199 total
Holdings
- 8,535,337(indirect: By Frazier Life Sciences X, L.P.)
Common Stock
Footnotes (2)
- [F1]The Restricted Stock Units ("RSUs") were granted on June 23, 2025 pursuant to the Registrant's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (i) the first anniversary of the date of grant or (ii) a Change in Control (as defined in the Registrant's 2022 Incentive Award Plan), in each case, subject to the non-employee director continuing in service on the Registrant's board of directors through such vesting date.
- [F2]The shares reported herein are held of record by Frazier Life Sciences X, L.P. ("FLS X"). The general partner of FLS X is FHMLS X, L.P., and the general partner of FHMLS X, L.P. is FHMLS X, L.L.C. James Topper, M.D., Ph.D., and Patrick Heron are the sole managing members of FHMLS X, L.L.C. and share voting and investment power of the securities held by FLS X. Dr. Topper and Mr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.